Vaccines for Children: List By Age, Benefits, Safety

Ketoconazole Cream

Given topically, it is not known whether ketoconazole cream could result in sufficient systemic absorption to produce detectable quantities in breast milk. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

I've Had A Rash On My Forehead For Months – It's Really Itchy And People Have Started Commenting On It

Q) I'VE had a rash on my forehead for six months. For the first couple, I used a steroid cream but was then told not to any more as it could damage my skin.

I switched to moisturising cream and calamine lotion.

2

Sun columnist Dr Zoe helps a reader who has an itchy rash that keeps coming backCredit: Olivia West

2

There are multiple potential causes to consider with forehead rashesCredit: Getty

The rash is noticeable and people have commented on it. It can be really itchy and, when I think it's cleared up, it will come back again.

A) Initially, I thought of the most common conditions that may affect the forehead area, such as seborrheic dermatitis and psoriasis.

But the image you sent of your skin helped me to rule these out as the distribution and appearance of the rash was not typical for either.

I see redness, inflammation and a bumpy appearance of the skin across the entire forehead, with no scaliness or rash in the hairline or eyebrows.

There are multiple potential causes to consider.

Contact dermatitis is an allergic response to something the skin has had contact with.

This could be products used on the face or hair (such as shampoo, which may run on to the forehead) or even a hat.

Rosacea is a skin condition that affects three times more women than men, but its impact on men must not be ignored.

DR WARNING

The 5 common meds that 'raise dementia risk' including for hay fever and anxiety

NO CLUE

I was size 6 when I found out I was 7 months pregnant - I'd only just given birth

FREAK SHOW

Inside deadly Mukbang craze…where people 'eat themselves to death' for £240k pay

HORROR

Turkey clinic held me hostage & charged EXTRA £8k to 'save me' after THEY botched op

In men, it most typically appears on and around the nose, but it can appear on the forehead, too.

Autoimmune conditions such as lupus can also cause rashes, sometimes exacerbated by the sun.

Dr Philippa Kaye on the signs, symptoms and best ways to avoid catching scabies

Inquire if there is a GP at your surgery with a special interest in dermatology.

Sometimes, if treatments are not effective, a skin biopsy can aid diagnosis. This would require a referral to a specialist.

Strong Prescription Growth And Competitive Advantage Drive Buy Rating For Arcutis Biotherapeutics

Mizuho Securities analyst Uy Ear has maintained their bullish stance on ARQT stock, giving a Buy rating on November 11.

Uy Ear has given his Buy rating due to a combination of factors indicating strong performance and growth potential for Arcutis Biotherapeutics. One of the key reasons is the impressive prescription growth for the Zoryve franchise, which reached new all-time highs in both total and new prescriptions. Zoryve Cream 0.15%, used for atopic dermatitis, and Zoryve Foam 0.3%, used for seborrheic dermatitis, both showed significant week-over-week growth, demonstrating robust market acceptance and expanding usage.Additionally, Zoryve Cream 0.3% for plaque psoriasis also displayed substantial weekly increases in prescriptions, suggesting strong demand and successful market penetration. Despite competition from VTAMA, which showed a decline in prescriptions, the consistent growth of the Zoryve products highlights Arcutis Biotherapeutics' competitive edge in the dermatology market. These factors collectively support Uy Ear's optimistic outlook and Buy rating for Arcutis Biotherapeutics' stock.

According to TipRanks, Ear is a 3-star analyst with an average return of 3.3% and a 41.90% success rate. Ear covers the Healthcare sector, focusing on stocks such as Arcutis Biotherapeutics, Alkermes, and Evolus.

In another report released on November 11, TD Cowen also maintained a Buy rating on the stock with a $20.00 price target.

TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.

Arcutis Biotherapeutics (ARQT) Company Description:

Arcutis Biotherapeutics, Inc. Engages in the development and commercialization of treatments for dermatological diseases. Its piepline consists of topical treatments for plaque psoriasis, atopic dermatitis, eczema, vitiligo, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne on June 1, 2016 and is headquartered in Westlake Village, CA.

---